Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Mesenchymal stem cells induced anti-inflammatory features in B cells from breast tumor draining lymph nodes.

Mehdipour F., Razmkhah M., Rezaeifard S., Bagheri M., Talei AR., Khalatbari B.

Laboratory Study on Chronic Inflammation, published in Cell Biol Int (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Cell Biol Int (2018)
Country
England
Reported sample size
—
Source database
PubMed
PMID
30288855
DOI
10.1002/cbin.11062
Citations
14

Abstract (original English)

The immune-modulatory effect of adipose-derived stem cells (ASCs) on B cells in cancer has not been well elucidated. Herein, the interaction between B cells and ASCs isolated from the breast fat of either normal (nASCs) or breast cancer women (cASCs) was investigated. B cells derived from breast tumor draining lymph nodes were co-cultured with nASCs or cASCs and B cells proliferation was assessed in direct and transwell assays. Moreover, B cells were co-cultured with cASCs, nASCs or mesenchymal stromal cells of the tumor tissue (TSCs) and B cell cytokine production was assessed using flow cytometery. cASCs or TSCs were co-cultured with either intact or B cell depleted lymphocytes and frequencies of CD25 + FoxP3 + Tregs, IL-10 + or IFN-γ + CD4 + T cells were assessed. Results showed that co-culture of B cells with ASCs in transwell chambers did not affect B cell proliferation. nASCs, however, was able to significantly reduce B cell proliferation in direct co-culture experiments (P = 0.004). The frequencies of IL-10 + , TNF-α + , IL-2 + , and IFN-γ + B cells were not significantly different in the co-cultures of B cells with ASCs or TSCs. But the TNF-α + / IL-10 + B cells ratio decreased in all co-cultures, a reduction merely significant in B cell-cASCs co-culture (P = 0.01). The frequencies of CD4 + T cells subsets in either intact or B cell depleted lymphocytes did not undergo

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnti-Inflammatory AgentsAntigens, CDB-LymphocytesBiomarkersBreast NeoplasmsCell ProliferationCoculture TechniquesCytokinesFemale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research